Latest Insider Transactions at Renovo Rx, Inc. (RNXT)
This section provides a real-time view of insider transactions for Renovo Rx, Inc. (RNXT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RenovoRx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RenovoRx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 26
2024
|
Ramtin Agah Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
40,983
+46.34%
|
-
|
Jan 26
2024
|
Robert J. Spiegel Director |
BUY
Open market or private purchase
|
Direct |
40,983
+50.0%
|
-
|
Jan 26
2024
|
Shaun Bagai Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,983
+12.29%
|
-
|
Jan 26
2024
|
Kirsten Angela Macfarlane Director |
BUY
Open market or private purchase
|
Direct |
40,983
+50.0%
|
-
|
Jan 26
2024
|
Laurence Marton Director |
BUY
Open market or private purchase
|
Direct |
8,196
+19.59%
|
-
|
Oct 03
2023
|
Angela Nelms Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,100
+46.05%
|
$1,100
$1.05 P/Share
|
Nov 03
2022
|
Laurence Marton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,438
+50.0%
|
$25,438
$1.7 P/Share
|
Jun 07
2022
|
Ramtin Agah Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,182
+44.45%
|
$5,182
$1.93 P/Share
|
May 19
2022
|
Shaun Bagai Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,500
+2.14%
|
$11,000
$2.05 P/Share
|
Mar 16
2022
|
Ramtin Agah Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
975,000
+50.0%
|
-
|
Mar 16
2022
|
Ramtin Agah Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
975,000
-99.87%
|
-
|
Aug 30
2021
|
Ramtin Agah Chief Medical Officer |
BUY
Conversion of derivative security
|
Direct |
1,295
+0.13%
|
-
|